Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.54 USD | +0.69% | -5.13% | +291.21% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With an expected P/E ratio at 34.09 and 22.21 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Corporate Financial Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+291.21% | 6.82B | - | ||
+41.92% | 22.2B | - | - | |
+3.69% | 5.56B | C | ||
+0.36% | 5B | C+ | ||
+43.75% | 4.72B | - | - | |
+8.12% | 4.55B | C+ | ||
+48.20% | 3.33B | - | C+ | |
+9.35% | 2.65B | - | ||
+10.95% | 1.72B | - | C- | |
+2.45% | 1.13B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- FTAI Stock
- FTAI Stock
- Ratings FORS TRAN